Sentinel lymph node biopsy in patients with ductal carcinoma in situ : A proposal
β Scribed by Kelly M. McMasters; Celia Chao; Sandra L. Wong; Robert C. G. Martin III; Michael J. Edwards
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 63 KB
- Volume
- 95
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with occult invasive tumor the need for axillary lymph node dissection.
π SIMILAR VOLUMES
Sentinel lymph node biopsy is frequently associated with identification of micrometastatic tumor deposits. The clinical relevance of identifying micrometastases in breast cancer must be evaluated in the statistical context of the lymph node evaluation strategy and the likelihood of missing a metasta
## BACKGROUND. It remains controversial whether modified radical neck dissection (MRND) for patients with papillary thyroid carcinoma improves prognosis. However, it is highly probable that the incidence of local recurrence is reduced by lymph node dissection. Sentinel lymph node (SLN) biopsy (SLN